Lebrikizumab maintains improvements in the patient-oriented eczema measure through 2 years of treatment in patients with moderate-to-severe atopic dermatitis [Abstract]
Author: | David Rosmarin, Andreas Wollenberg, Mark Boguniewicz, Carolyn Jack, Sebastien Barbarot, Vivian Shi, Marjolein de Bruin-Weller, Louise DeLuca-Carter, Evangeline Pierce, Chaoran Hu, Chunyuan Liu, Heidi Crane, Laia Bardolet, Martin Steinhoff |
---|---|
Frontdoor URL | https://opus.bibliothek.uni-augsburg.de/opus4/111463 |
ISSN: | 0091-6749OPAC |
Parent Title (English): | Journal of Allergy and Clinical Immunology |
Publisher: | Elsevier BV |
Type: | Article |
Language: | English |
Date of first Publication: | 2024/02/05 |
Publishing Institution: | Universität Augsburg |
Release Date: | 2024/02/20 |
Tag: | Immunology; Immunology and Allergy |
Volume: | 153 |
Issue: | 2, Supplement |
First Page: | AB7 |
DOI: | https://doi.org/10.1016/j.jaci.2023.11.045 |
Institutes: | Medizinische Fakultät |
Medizinische Fakultät / Universitätsklinikum | |
Medizinische Fakultät / Lehrstuhl für Dermatologie |